China’s 2026 Spring Festival film season delivered a paradox: a record number of screenings but the weakest box-office haul in eight years. By 09:00 on 24 February the nationwide Spring Festival box office stood at 57.52亿元 (5.75 billion yuan), a 39.5% drop year‑on‑year, while admissions fell 35.8% to about 120 million viewers. Exhibitors increased supply—435万场 (4.35 million showings)—and cut prices to lure audiences, yet those efforts did not translate into effective demand.
The top title, Fei Chi Ren 3, took nearly 30亿元, a respectable sum but not the kind of industry‑reordering blockbuster that can carry an entire holiday window. Other films performed unevenly: the martial‑arts title Biao Ren: Wind Rises in the Desert recovered strongly on word of mouth to roughly 8亿元, while films with middling acclaim such as Xinghe Rumeng were rapidly dropped from schedules. The result was a head‑heavy market in which the top few titles ate up attention while mid‑rank films starved for screenings.
The market response was immediate. Film and media stocks plunged on the first trading day after the holiday; multiple companies saw sharp share price declines as investors repriced the sector. A rumour that a prominent producer intended to disband its film division after last year’s Cannes success briefly circulated and, although later denied, underlined how fragile investor confidence has become.
Structural changes help explain the slide. Younger audiences are disengaging: in 2025, viewers under 24 made up roughly 15% of cinema attendances versus 38% in 2019, while the 30–39 age group rose to about 40%. The long tail of the theatrical calendar has thinned: aside from the crowded Spring Festival, National Day and summer windows, distributors now treat most mid‑season slots as high‑risk. That concentrates bets, accelerates scheduling churn, and leaves little room for slow‑burn films to find an audience.
Short‑form dramas and platforms have eaten into people’s leisure time and distributors’ revenue pools. Red‑fruit short dramas launched in 2023 now report daily actives in the hundreds of millions and have generated multi‑billion‑view franchises. Industry forecasts put the micro‑short market at roughly 634 billion yuan in 2025 and project it could exceed 1,000 billion yuan by 2027—figures that dwarf cinema receipts. A stark comparator: China’s full‑year theatrical box office in 2025 was about 518.32亿元, while one technology giant reported a single quarter profit of 631.33亿元, underscoring how limited the box‑office ceiling has become.
This is not just a domestic phenomenon. Overseas, legacy theatrical markets have also softened: South Korea is struggling to launch projects at previoulsy normal rates, while Japan’s top‑grossing films are increasingly anime theatrical adaptations rather than live‑action releases. The international trend reinforces the point that cinema must reassert the unique experiential value that small screens cannot reproduce—IMAX sightlines, Dolby soundscapes and collective, appointment‑viewing moments.
For Chinese filmmakers and exhibitors, the implication is clear: the business must stop buying its way to attention with star salaries and instead invest in work that justifies the trip to a cinema. That may mean more event cinema, clearer windows between theatrical and streaming releases, and smarter scheduling that gives promising titles time to build. Absent such changes, the industry faces continued revenue pressure, consolidation, and further downgrades from capital markets.